Sponsors: []Modifications: (I)  Benzylpiperazine;(J)(K)(L)(M)(N)(O)(P)(Q)(R)(S)(T)(U)(V)(W)(X)(Y)(Z)(AA)(BB)(CC)(DD)(EE)(FF)(GG)(HH)(II)(JJ)(KK)(LL)(MM)(NN)(OO)(PP)(QQ)(RR)(SS)(TT)(UU)(VV)(WW)(XX)(YY)(ZZ)(AAA)(BBB)(CCC)(DDD)(2)  AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;(3)(4)  Fluoromethcathinone;(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)  JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;(15)  JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;(16)(17)(18)(19)  RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;(20)(21)(22)(23)and(24).Full text:



Utah State Legislature












Legislators

By Session (1896-Current)
Alphabetical (Historical)
Find by Address/Map
More


Bills

Bills/Bill Requests
Passed Bills
2017 Bills

Keyword Search
Reading Calendars
Tracking Service
More


Committees

All Committees
Appropriations
Commissions

Independent Legislative Ethics Commission
Interim
Standing
Subcommittees
Task Forces
Bills In Committees


Utah Code / Constitution


Title/Chapter/Section
Keyword Search 

Utah Constitution
Laws of Utah 1851-ongoing
Utah Territorial Laws 
More


Senate

Main Page 
About The Senate 
Leadership 
Roster 
Seating Chart 
District Maps 
Extraordinary Sessions 
Reading Calendars 
Past Floor Debates 
Senate Journals 


House

Main Page
About the House 
Leadership 
Roster 
Seating Chart 
District Maps 
Reading Calendars 
Past Floor Debates 
Journals 
Conflict of Interest Forms 


Legislative Guide 

Legislative Guide
Civic Programs
GRAMA (Records Requests)


Publications

Search Publications
Appropriations
Audits
Bagels & Briefings
Briefing Papers
Digest of Legislation
Legislative Drafting Manual

Journals

Interim Highlights

Legislative Rules
GRAMA (Records Requests)
Public Email
State Organization Charts
YouTube Channel
Requests for Proposals and Legal Notices
More


Legislative Histories

Legislative History Resources
How to Research
Bill Drafting/Research Files (1990-Ongoing)

Working Bills (1896-1989)
Interim Committee Histories (1990-Ongoing) 
Journals
Past House Floor Debates
Past Senate Floor Debates
More


Staff Offices

All Legislative Offices
Auditor General
Fiscal Analyst
Printing
Research and General Counsel
Staff Awards
Job Opportunities
More


Links of Interest

Utah Administrative Rules
Courts
Utah State Capitol
State of Utah
Federal Legislation
More






 

Download Zipped Introduced WordPerfect HB0254.ZIP
[Status][Bill Documents][Fiscal Note][Bills Directory]


H.B. 254





            
1

    
 CONTROLLED SUBSTANCES AMENDMENTS



            
2

    
2012 GENERAL SESSION

            
3

    
STATE OF UTAH

            
4

    


 Chief Sponsor:  Gage Froerer



            
5

    



Senate Sponsor:  






____________





            
6

    

            
7

    
 LONG TITLE
            
8

    
 General Description:
            
9

    
    This bill modifies the Utah Controlled Substances Act.
            
10

    
 Highlighted Provisions:
            
11

    
    This bill:
            
12

    
    .    adds benzylpiperazine to Schedule I of the controlled substances list; and
            
13

    
    .    adds AM-2201, RCS-4, JWH-210, and JWH-203 to the list of listed controlled
            
14

    
substances.
            
15

    
 Money Appropriated in this Bill:
            
16

    
    None
            
17

    
 Other Special Clauses:
            
18

    
    None
            
19

    
 Utah Code Sections Affected:
            
20

    
AMENDS:
            
21

    
     58-37-4, as last amended by Laws of Utah 2011, Chapter 12
            
22

    
     58-37-4.2, as enacted by Laws of Utah 2011, Chapter 12
            
23

    

            
24

    
Be it enacted by the Legislature of the state of Utah:
            
25

    
    Section 1.  
Section  
58-37-4

 is amended to read:
            
26

    
     58-37-4.  Schedules of controlled substances -- Schedules I through V -- Findings
            
27

    
 required -- Specific substances included in schedules.

            
28


    
    (1)  There are established five schedules of controlled substances known as Schedules I,
            
29

    
II, III, IV, and V which consist of substances listed in this section.
            
30

    
    (2)  Schedules I, II, III, IV, and V consist of the following drugs or other substances by
            
31

    
the official name, common or usual name, chemical name, or brand name designated:
            
32

    
    (a)  Schedule I:
            
33

    
    (i)  Unless specifically excepted or unless listed in another schedule, any of the
            
34

    
following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
            
35

    
ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
            
36

    
chemical designation:
            
37

    
    (A)  Acetyl-alpha-methylfentanyl
            
38

    
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
            
39

    
    (B)  Acetylmethadol;
            
40

    
    (C)  Allylprodine;
            
41

    
    (D)  Alphacetylmethadol, except levo-alphacetylmethadol also known as
            
42

    
levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
            
43

    
    (E)  Alphameprodine;
            
44

    
    (F)  Alphamethadol;
            
45

    
    (G)  Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
            
46

    
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
            
47

    
    (H)  Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
            
48

    
piperidinyl]-N-phenylpropanamide);
            
49

    
    (I)  Benzylpiperazine;
            
50

    
    [(I)] (J)  Benzethidine;
            
51

    
    [(J)] (K)  Betacetylmethadol;
            
52

    
    [(K)] (L)  Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
            
53

    
piperidinyl]-N-phenylpropanamide);
            
54

    
    [(L)] (M)  Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
            
55

    
phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
            
56

    
    [(M)] (N)  Betameprodine;
            
57

    
    [(N)] (O)  Betamethadol;
            
58

    
    [(O)] (P)  Betaprodine;

            
59


    
    [(P)] (Q)  Clonitazene;
            
60

    
    [(Q)] (R)  Dextromoramide;
            
61

    
    [(R)] (S)  Diampromide;
            
62

    
    [(S)] (T)  Diethylthiambutene;
            
63

    
    [(T)] (U)  Difenoxin;
            
64

    
    [(U)] (V)  Dimenoxadol;
            
65

    
    [(V)] (W)  Dimepheptanol;
            
66

    
    [(W)] (X)  Dimethylthiambutene;
            
67

    
    [(X)] (Y)  Dioxaphetyl butyrate;
            
68

    
    [(Y)] (Z)  Dipipanone;
            
69

    
    [(Z)] (AA)  Ethylmethylthiambutene;
            
70

    
    [(AA)] (BB)  Etonitazene;
            
71

    
    [(BB)] (CC)  Etoxeridine;
            
72

    
    [(CC)] (DD)  Furethidine;
            
73

    
    [(DD)] (EE)  Hydroxypethidine;
            
74

    
    [(EE)] (FF)  Ketobemidone;
            
75

    
    [(FF)] (GG)  Levomoramide;
            
76

    
    [(GG)] (HH)  Levophenacylmorphan;
            
77

    
    [(HH)] (II)  Morpheridine;
            
78

    
    [(II)] (JJ)  MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
            
79

    
    [(JJ)] (KK)  Noracymethadol;
            
80

    
    [(KK)] (LL)  Norlevorphanol;
            
81

    
    [(LL)] (MM)  Normethadone;
            
82

    
    [(MM)] (NN)  Norpipanone;
            
83

    
    [(NN)] (OO)  Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-
            
84

    
piperidinyl] propanamide;
            
85

    
    [(OO)] (PP)  PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
            
86

    
    [(PP)] (QQ)  Phenadoxone;
            
87

    
    [(QQ)] (RR)  Phenampromide;
            
88

    
    [(RR)] (SS)  Phenomorphan;
            
89

    
    [(SS)] (TT)  Phenoperidine;

            
90


    
    [(TT)] (UU)  Piritramide;
            
91

    
    [(UU)] (VV)  Proheptazine;
            
92

    
    [(VV)] (WW)  Properidine;
            
93

    
    [(WW)] (XX)  Propiram;
            
94

    
    [(XX)] (YY)  Racemoramide;
            
95

    
    [(YY)] (ZZ)  Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
            
96

    
propanamide;
            
97

    
    [(ZZ)] (AAA)  Tilidine;
            
98

    
    [(AAA)] (BBB)  Trimeperidine;
            
99

    
    [(BBB)] (CCC)  3-methylfentanyl, including the optical and geometric isomers
            
100

    
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
            
101

    
    [(CCC)] (DDD)  3-methylthiofentanyl
            
102

    
(N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
            
103

    
    (ii)  Unless specifically excepted or unless listed in another schedule, any of the
            
104

    
following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
            
105

    
salts, isomers, and salts of isomers is possible within the specific chemical designation:
            
106

    
    (A)  Acetorphine;
            
107

    
    (B)  Acetyldihydrocodeine;
            
108

    
    (C)  Benzylmorphine;
            
109

    
    (D)  Codeine methylbromide;
            
110

    
    (E)  Codeine-N-Oxide;
            
111

    
    (F)  Cyprenorphine;
            
112

    
    (G)  Desomorphine;
            
113

    
    (H)  Dihydromorphine;
            
114

    
    (I)  Drotebanol;
            
115

    
    (J)  Etorphine (except hydrochloride salt);
            
116

    
    (K)  Heroin;
            
117

    
    (L)  Hydromorphinol;
            
118

    
    (M)  Methyldesorphine;
            
119

    
    (N)  Methylhydromorphine;
            
120

    
    (O)  Morphine methylbromide;

            
121


    
    (P)  Morphine methylsulfonate;
            
122

    
    (Q)  Morphine-N-Oxide;
            
123

    
    (R)  Myrophine;
            
124

    
    (S)  Nicocodeine;
            
125

    
    (T)  Nicomorphine;
            
126

    
    (U)  Normorphine;
            
127

    
    (V)  Pholcodine; and
            
128

    
    (W)  Thebacon.
            
129

    
    (iii)  Unless specifically excepted or unless listed in another schedule, any material,
            
130

    
compound, mixture, or preparation which contains any quantity of the following hallucinogenic
            
131

    
substances, or which contains any of their salts, isomers, and salts of isomers when the
            
132

    
existence of the salts, isomers, and salts of isomers is possible within the specific chemical
            
133

    
designation; as used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and
            
134

    
geometric isomers:
            
135

    
    (A)  Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
            
136

    
.-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
            
137

    
    (B)  4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
            
138

    
4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
            
139

    
    (C)  4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
            
140

    
2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
            
141

    
    (D)  2,5-dimethoxyamphetamine, some trade or other names:
            
142

    
2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
            
143

    
    (E)  2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
            
144

    
    (F)  4-methoxyamphetamine, some trade or other names:
            
145

    
4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
            
146

    
    (G)  5-methoxy-3,4-methylenedioxyamphetamine;
            
147

    
    (H)  4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
            
148

    
4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
            
149

    
    (I)  3,4-methylenedioxy amphetamine;
            
150

    
    (J)  3,4-methylenedioxymethamphetamine (MDMA);
            
151

    
    (K)  3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-

            
152


    
alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
            
153

    
    (L)  N-hydroxy-3,4-methylenedioxyamphetamine, also known as
            
154

    
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
            
155

    
    (M)  3,4,5-trimethoxy amphetamine;
            
156

    
    (N)  Bufotenine, some trade and other names:
            
157

    
3-(.-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
            
158

    
N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
            
159

    
    (O)  Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
            
160

    
    (P)  Dimethyltryptamine, some trade or other names: DMT;
            
161

    
    (Q)  Ibogaine, some trade and other names:
            
162

    
7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
            
163

    
[5,4-b] indole; Tabernanthe iboga;
            
164

    
    (R)  Lysergic acid diethylamide;
            
165

    
    (S)  Marijuana;
            
166

    
    (T)  Mescaline;
            
167

    
    (U)  Parahexyl, some trade or other names:
            
168

    
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
            
169

    
    (V)  Peyote, meaning all parts of the plant presently classified botanically as
            
170

    
Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
            
171

    
any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
            
172

    
preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
            
173

    
    (W)  N-ethyl-3-piperidyl benzilate;
            
174

    
    (X)  N-methyl-3-piperidyl benzilate;
            
175

    
    (Y)  Psilocybin;
            
176

    
    (Z)  Psilocyn;
            
177

    
    (AA)  Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
            
178

    
(cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis
            
179

    
plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
            
180

    
and their isomers with similar chemical structure and pharmacological activity to those
            
181

    
substances contained in the plant, such as the following: .1 cis or trans tetrahydrocannabinol,
            
182

    
and their optical isomers .6 cis or trans tetrahydrocannabinol, and their optical isomers .3,4

            
183


    
cis or trans tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
            
184

    
substances is not internationally standardized, compounds of these structures, regardless of
            
185

    
numerical designation of atomic positions covered;
            
186

    
    (BB)  Ethylamine analog of phencyclidine, some trade or other names:
            
187

    
N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
            
188

    
N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
            
189

    
    (CC)  Pyrrolidine analog of phencyclidine, some trade or other names:
            
190

    
1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
            
191

    
    (DD)  Thiophene analog of phencyclidine, some trade or other names:
            
192

    
1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
            
193

    
    (EE)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
            
194

    
    (iv)  Unless specifically excepted or unless listed in another schedule, any material
            
195

    
compound, mixture, or preparation which contains any quantity of the following substances
            
196

    
having a depressant effect on the central nervous system, including its salts, isomers, and salts
            
197

    
of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
            
198

    
specific chemical designation:
            
199

    
    (A)  Mecloqualone; and
            
200

    
    (B)  Methaqualone.
            
201

    
    (v)  Any material, compound, mixture, or preparation containing any quantity of the
            
202

    
following substances having a stimulant effect on the central nervous system, including their
            
203

    
salts, isomers, and salts of isomers:
            
204

    
    (A)  Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
            
205

    
4,5-dihydro-5-phenyl-2-oxazolamine;
            
206

    
    (B)  Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
            
207

    
alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
            
208

    
    (C)  Fenethylline;
            
209

    
    (D)  Methcathinone, some other names: 2-(methylamino)-propiophenone;
            
210

    
alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
            
211

    
alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
            
212

    
methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
            
213

    
optical isomers;

            
214


    
    (E)  (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
            
215

    
    (F)  N-ethylamphetamine; and
            
216

    
    (G)  N,N-dimethylamphetamine, also known as
            
217

    
N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
            
218

    
    (vi)  Any material, compound, mixture, or preparation which contains any quantity of
            
219

    
the following substances, including their optical isomers, salts, and salts of isomers, subject to
            
220

    
temporary emergency scheduling:
            
221

    
    (A)  N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
            
222

    
    (B)  N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
            
223

    
    (vii)  Unless specifically excepted or unless listed in another schedule, any material,
            
224

    
compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
            
225

    
(gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
            
226

    
    (b)  Schedule II:
            
227

    
    (i)  Unless specifically excepted or unless listed in another schedule, any of the
            
228

    
following substances whether produced directly or indirectly by extraction from substances of
            
229

    
vegetable origin, or independently by means of chemical synthesis, or by a combination of
            
230

    
extraction and chemical synthesis:
            
231

    
    (A)  Opium and opiate, and any salt, compound, derivative, or preparation of opium or
            
232

    
opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
            
233

    
and their respective salts, but including:
            
234

    
    (I)  Raw opium;
            
235

    
    (II)  Opium extracts;
            
236

    
    (III)  Opium fluid;
            
237

    
    (IV)  Powdered opium;
            
238

    
    (V)  Granulated opium;
            
239

    
    (VI)  Tincture of opium;
            
240

    
    (VII)  Codeine;
            
241

    
    (VIII)  Ethylmorphine;
            
242

    
    (IX)  Etorphine hydrochloride;
            
243

    
    (X)  Hydrocodone;
            
244

    
    (XI)  Hydromorphone;

            
245


    
    (XII)  Metopon;
            
246

    
    (XIII)  Morphine;
            
247

    
    (XIV)  Oxycodone;
            
248

    
    (XV)  Oxymorphone; and
            
249

    
    (XVI)  Thebaine;
            
250

    
    (B)  Any salt, compound, derivative, or preparation which is chemically equivalent or
            
251

    
identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
            
252

    
substances may not include the isoquinoline alkaloids of opium;
            
253

    
    (C)  Opium poppy and poppy straw;
            
254

    
    (D)  Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
            
255

    
any salt, compound, derivative, or preparation which is chemically equivalent or identical with
            
256

    
any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
            
257

    
and salts of isomers and derivatives, whether derived from the coca plant or synthetically
            
258

    
produced, except the substances may not include decocainized coca leaves or extraction of coca
            
259

    
leaves, which extractions do not contain cocaine or ecgonine; and
            
260

    
    (E)  Concentrate of poppy straw, which means the crude extract of poppy straw in either
            
261

    
liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
            
262

    
    (ii)  Unless specifically excepted or unless listed in another schedule, any of the
            
263

    
following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
            
264

    
ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
            
265

    
chemical designation, except dextrorphan and levopropoxyphene:
            
266

    
    (A)  Alfentanil;
            
267

    
    (B)  Alphaprodine;
            
268

    
    (C)  Anileridine;
            
269

    
    (D)  Bezitramide;
            
270

    
    (E)  Bulk dextropropoxyphene (nondosage forms);
            
271

    
    (F)  Carfentanil;
            
272

    
    (G)  Dihydrocodeine;
            
273

    
    (H)  Diphenoxylate;
            
274

    
    (I)  Fentanyl;
            
275

    
    (J)  Isomethadone;

            
276


    
    (K)  Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
            
277

    
levomethadyl acetate, or LAAM;
            
278

    
    (L)  Levomethorphan;
            
279

    
    (M)  Levorphanol;
            
280

    
    (N)  Metazocine;
            
281

    
    (O)  Methadone;
            
282

    
    (P)  Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
            
283

    
    (Q)  Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
            
284

    
acid;
            
285

    
    (R)  Pethidine (meperidine);
            
286

    
    (S)  Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
            
287

    
    (T)  Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
            
288

    
    (U)  Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
            
289

    
    (V)  Phenazocine;
            
290

    
    (W)  Piminodine;
            
291

    
    (X)  Racemethorphan;
            
292

    
    (Y)  Racemorphan;
            
293

    
    (Z)  Remifentanil; and
            
294

    
    (AA)  Sufentanil.
            
295

    
    (iii)  Unless specifically excepted or unless listed in another schedule, any material,
            
296

    
compound, mixture, or preparation which contains any quantity of the following substances
            
297

    
having a stimulant effect on the central nervous system:
            
298

    
    (A)  Amphetamine, its salts, optical isomers, and salts of its optical isomers;
            
299

    
    (B)  Methamphetamine, its salts, isomers, and salts of its isomers;
            
300

    
    (C)  Phenmetrazine and its salts; and
            
301

    
    (D)  Methylphenidate.
            
302

    
    (iv)  Unless specifically excepted or unless listed in another schedule, any material,
            
303

    
compound, mixture, or preparation which contains any quantity of the following substances
            
304

    
having a depressant effect on the central nervous system, including its salts, isomers, and salts
            
305

    
of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
            
306

    
specific chemical designation:

            
307


    
    (A)  Amobarbital;
            
308

    
    (B)  Glutethimide;
            
309

    
    (C)  Pentobarbital;
            
310

    
    (D)  Phencyclidine;
            
311

    
    (E)  Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
            
312

    
1-piperidinocyclohexanecarbonitrile (PCC); and
            
313

    
    (F)  Secobarbital.
            
314

    
    (v) (A)  Unless specifically excepted or unless listed in another schedule, any material,
            
315

    
compound, mixture, or preparation which contains any quantity of Phenylacetone.
            
316

    
    (B)  Some of these substances may be known by trade or other names:
            
317

    
phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
            
318

    
    (vi)  Nabilone, another name for nabilone:
            
319

    
(.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
            
320

    
6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
            
321

    
    (c)  Schedule III:
            
322

    
    (i)  Unless specifically excepted or unless listed in another schedule, any material,
            
323

    
compound, mixture, or preparation which contains any quantity of the following substances
            
324

    
having a stimulant effect on the central nervous system, including its salts, isomers whether
            
325

    
optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
            
326

    
and salts of isomers is possible within the specific chemical designation:
            
327

    
    (A)  Those compounds, mixtures, or preparations in dosage unit form containing any
            
328

    
stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
            
329

    
listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
            
330

    
Code of Federal Regulations, and any other drug of the quantitive composition shown in that
            
331

    
list for those drugs or which is the same except that it contains a lesser quantity of controlled
            
332

    
substances;
            
333

    
    (B)  Benzphetamine;
            
334

    
    (C)  Chlorphentermine;
            
335

    
    (D)  Clortermine; and
            
336

    
    (E)  Phendimetrazine.
            
337

    
    (ii)  Unless specifically excepted or unless listed in another schedule, any material,

            
338


    
compound, mixture, or preparation which contains any quantity of the following substances
            
339

    
having a depressant effect on the central nervous system:
            
340

    
    (A)  Any compound, mixture, or preparation containing amobarbital, secobarbital,
            
341

    
pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
            
342

    
which are not listed in any schedule;
            
343

    
    (B)  Any suppository dosage form containing amobarbital, secobarbital, or
            
344

    
pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
            
345

    
Administration for marketing only as a suppository;
            
346

    
    (C)  Any substance which contains any quantity of a derivative of barbituric acid or any
            
347

    
salt of any of them;
            
348

    
    (D)  Chlorhexadol;
            
349

    
    (E)  Buprenorphine;
            
350

    
    (F)  Any drug product containing gamma hydroxybutyric acid, including its salts,
            
351

    
isomers, and salts of isomers, for which an application is approved under the federal Food,
            
352

    
Drug, and Cosmetic Act, Section 505;
            
353

    
    (G)  Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
            
354

    
. -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
            
355

    
    (H)  Lysergic acid;
            
356

    
    (I)  Lysergic acid amide;
            
357

    
    (J)  Methyprylon;
            
358

    
    (K)  Sulfondiethylmethane;
            
359

    
    (L)  Sulfonethylmethane;
            
360

    
    (M)  Sulfonmethane; and
            
361

    
    (N)  Tiletamine and zolazepam or any of their salts, some trade or other names for a
            
362

    
tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
            
363

    
2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
            
364

    
4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
            
365

    
flupyrazapon.
            
366

    
    (iii)  Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
            
367

    
U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
            
368

    
(6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or

            
369


    
(-)-delta-9-(trans)-tetrahydrocannabinol.
            
370

    
    (iv)  Nalorphine.
            
371

    
    (v)  Unless specifically excepted or unless listed in another schedule, any material,
            
372

    
compound, mixture, or preparation containing limited quantities of any of the following
            
373

    
narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
            
374

    
    (A)  Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
            
375

    
milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
            
376

    
opium;
            
377

    
    (B)  Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
            
378

    
milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
            
379

    
therapeutic amounts;
            
380

    
    (C)  Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
            
381

    
than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
            
382

    
alkaloid of opium;
            
383

    
    (D)  Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
            
384

    
than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
            
385

    
recognized therapeutic amounts;
            
386

    
    (E)  Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
            
387

    
milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
            
388

    
therapeutic amounts;
            
389

    
    (F)  Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
            
390

    
than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
            
391

    
recognized therapeutic amounts;
            
392

    
    (G)  Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
            
393

    
more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
            
394

    
recognized therapeutic amounts; and
            
395

    
    (H)  Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
            
396

    
one or more active, non-narcotic ingredients in recognized therapeutic amounts.
            
397

    
    (vi)  Unless specifically excepted or unless listed in another schedule, anabolic steroids
            
398

    
including any of the following or any isomer, ester, salt, or derivative of the following that
            
399

    
promotes muscle growth:

            
400


    
    (A)  Boldenone;
            
401

    
    (B)  Chlorotestosterone (4-chlortestosterone);
            
402

    
    (C)  Clostebol;
            
403

    
    (D)  Dehydrochlormethyltestosterone;
            
404

    
    (E)  Dihydrotestosterone (4-dihydrotestosterone);
            
405

    
    (F)  Drostanolone;
            
406

    
    (G)  Ethylestrenol;
            
407

    
    (H)  Fluoxymesterone;
            
408

    
    (I)  Formebulone (formebolone);
            
409

    
    (J)  Mesterolone;
            
410

    
    (K)  Methandienone;
            
411

    
    (L)  Methandranone;
            
412

    
    (M)  Methandriol;
            
413

    
    (N)  Methandrostenolone;
            
414

    
    (O)  Methenolone;
            
415

    
    (P)  Methyltestosterone;
            
416

    
    (Q)  Mibolerone;
            
417

    
    (R)  Nandrolone;
            
418

    
    (S)  Norethandrolone;
            
419

    
    (T)  Oxandrolone;
            
420

    
    (U)  Oxymesterone;
            
421

    
    (V)  Oxymetholone;
            
422

    
    (W)  Stanolone;
            
423

    
    (X)  Stanozolol;
            
424

    
    (Y)  Testolactone;
            
425

    
    (Z)  Testosterone; and
            
426

    
    (AA)  Trenbolone.
            
427

    
    (vii)  Anabolic steroids expressly intended for administration through implants to cattle
            
428

    
or other nonhuman species, and approved by the Secretary of Health and Human Services for
            
429

    
use, may not be classified as a controlled substance.
            
430

    
    (d)  Schedule IV:

            
431


    
    (i)  Unless specifically excepted or unless listed in another schedule, any material,
            
432

    
compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
            
433

    
less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
            
434

    
    (ii)  Unless specifically excepted or unless listed in another schedule, any material,
            
435

    
compound, mixture, or preparation which contains any quantity of the following substances,
            
436

    
including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
            
437

    
salts of isomers is possible within the specific chemical designation:
            
438

    
    (A)  Alprazolam;
            
439

    
    (B)  Barbital;
            
440

    
    (C)  Bromazepam;
            
441

    
    (D)  Butorphanol;
            
442

    
    (E)  Camazepam;
            
443

    
    (F)  Carisoprodol;
            
444

    
    (G)  Chloral betaine;
            
445

    
    (H)  Chloral hydrate;
            
446

    
    (I)  Chlordiazepoxide;
            
447

    
    (J)  Clobazam;
            
448

    
    (K)  Clonazepam;
            
449

    
    (L)  Clorazepate;
            
450

    
    (M)  Clotiazepam;
            
451

    
    (N)  Cloxazolam;
            
452

    
    (O)  Delorazepam;
            
453

    
    (P)  Diazepam;
            
454

    
    (Q)  Dichloralphenazone;
            
455

    
    (R)  Estazolam;
            
456

    
    (S)  Ethchlorvynol;
            
457

    
    (T)  Ethinamate;
            
458

    
    (U)  Ethyl loflazepate;
            
459

    
    (V)  Fludiazepam;
            
460

    
    (W)  Flunitrazepam;
            
461

    
    (X)  Flurazepam;

            
462


    
    (Y)  Halazepam;
            
463

    
    (Z)  Haloxazolam;
            
464

    
    (AA)  Ketazolam;
            
465

    
    (BB)  Loprazolam;
            
466

    
    (CC)  Lorazepam;
            
467

    
    (DD)  Lormetazepam;
            
468

    
    (EE)  Mebutamate;
            
469

    
    (FF)  Medazepam;
            
470

    
    (GG)  Meprobamate;
            
471

    
    (HH)  Methohexital;
            
472

    
    (II)  Methylphenobarbital (mephobarbital);
            
473

    
    (JJ)  Midazolam;
            
474

    
    (KK)  Nimetazepam;
            
475

    
    (LL)  Nitrazepam;
            
476

    
    (MM)  Nordiazepam;
            
477

    
    (NN)  Oxazepam;
            
478

    
    (OO)  Oxazolam;
            
479

    
    (PP)  Paraldehyde;
            
480

    
    (QQ)  Pentazocine;
            
481

    
    (RR)  Petrichloral;
            
482

    
    (SS)  Phenobarbital;
            
483

    
    (TT)  Pinazepam;
            
484

    
    (UU)  Prazepam;
            
485

    
    (VV)  Quazepam;
            
486

    
    (WW)  Temazepam;
            
487

    
    (XX)  Tetrazepam;
            
488

    
    (YY)   Triazolam;
            
489

    
    (ZZ)   Zaleplon; and
            
490

    
    (AAA)   Zolpidem.
            
491

    
    (iii)  Any material, compound, mixture, or preparation of fenfluramine which contains
            
492

    
any quantity of the following substances, including its salts, isomers whether optical, position,

            
493


    
or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
            
494

    
isomers is possible.
            
495

    
    (iv)  Unless specifically excepted or unless listed in another schedule, any material,
            
496

    
compound, mixture, or preparation which contains any quantity of the following substances
            
497

    
having a stimulant effect on the central nervous system, including its salts, isomers whether
            
498

    
optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
            
499

    
isomers, and salts of isomers is possible within the specific chemical designation:
            
500

    
    (A)  Cathine ((+)-norpseudoephedrine);
            
501

    
    (B)  Diethylpropion;
            
502

    
    (C)  Fencamfamine;
            
503

    
    (D)  Fenproprex;
            
504

    
    (E)  Mazindol;
            
505

    
    (F)  Mefenorex;
            
506

    
    (G)  Modafinil;
            
507

    
    (H)  Pemoline, including organometallic complexes and chelates thereof;
            
508

    
    (I)  Phentermine;
            
509

    
    (J)  Pipradrol;
            
510

    
    (K)  Sibutramine; and
            
511

    
    (L)  SPA ((-)-1-dimethylamino-1,2-diphenylethane).
            
512

    
    (v)  Unless specifically excepted or unless listed in another schedule, any material,
            
513

    
compound, mixture, or preparation which contains any quantity of dextropropoxyphene
            
514

    
(alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
            
515

    
    (e)  Schedule V: Any compound, mixture, or preparation containing any of the
            
516

    
following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous
            
517

    
base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
            
518

    
sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
            
519

    
qualities other than those possessed by the narcotic drug alone:
            
520

    
    (i)  not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
            
521

    
    (ii)  not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
            
522

    
grams;
            
523

    
    (iii)  not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100

            
524


    
grams;
            
525

    
    (iv)  not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
            
526

    
atropine sulfate per dosage unit;
            
527

    
    (v)  not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
            
528

    
    (vi)  not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
            
529

    
atropine sulfate per dosage unit; and
            
530

    
    (vii)  unless specifically exempted or excluded or unless listed in another schedule, any
            
531

    
material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
            
532

    
effect on the central nervous system, including its salts, isomers, and salts of isomers.
            
533

    
    Section 2.  
Section  
58-37-4.2

 is amended to read:
            
534

    
     58-37-4.2.  Listed controlled substances.
            
535

    
    The following substances, their analogs, homologs, and synthetic equivalents are listed
            
536

    
controlled substances:
            
537

    
    (1)   AM-694; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone;
            
538

    
    (2)  AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;
            
539

    
    [(2)] (3)  CP 47,497 and its C6, C8, and C9 homologs;
            
540

    
2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol;
            
541

    
    (4)  Fluoromethcathinone;
            
542

    
    [(3)] (5)  HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)
            
543

    
-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
            
544

    
    [(4)] (6)  HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
            
545

    
methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
            
546

    
    [(5)] (7)  JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;
            
547

    
    [(6)] (8)  JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as
            
548

    
1-Pentyl-3-(1-naphthoyl)indole};
            
549

    
    [(7)] (9)  JWH-019; 1-hexyl-3-(1-naphthoyl)indole;
            
550

    
    [(8)] (10)  JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as
            
551

    
1-Butyl-3-(1-naphthoyl)indole};
            
552

    
    [(9)] (11)  JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;
            
553

    
    [(10)] (12)  JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);
            
554

    
    [(11)] (13)  JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;

            
555


    
    (14)  JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;
            
556

    
    (15)  JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;
            
557

    
    [(12)] (16)  JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;
            
558

    
    [(13)] (17)  JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;
            
559

    
    [(14)] (18)  JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;
            
560

    
    (19)  RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;
            
561

    
    [(15)] (20)  RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also
            
562

    
known as BTW-8 and SR-18};
            
563

    
    [(16)] (21)  4-methylmethcathinone {also known as mephedrone};
            
564

    
    [(17)] (22)  3,4-methylenedioxypyrovalerone {also known as MDPV};
            
565

    
    [(18)] (23)  3,4-Methylenedioxymethcathinone {also known as methylone}; and
            
566

    
    [(19)] (24)  4-methoxymethcathinone[;].
            
567

    
    [(20)  4-Fluoromethcathinone; and]
            
568

    
    [(21)  3-Fluoromethcathinone.]




 Legislative Review Note
    as of   1-3-12  6:20 AM

 Office of Legislative Research and General Counsel
[Bill Documents][Bills Directory]









Who represents me?





Remember my Legislators





State Senate
		350 North State, Suite 320
		PO Box 145115
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1035
		Fax: (801) 326-1475



House of Representatives
		350 North State, Suite 350
		PO Box 145030
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1029
		Fax: (801) 326-1544










Home
Mobile Site
Site Map
Calendar
Code / Constitution
House
Senate

Terms of Use/Privacy Policy

ADA
Utah.gov







